Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is ...

While the rate of HIV in Kampala, Uganda, is more than double the national average, a recent survey of displaced youths in ...

The US launches long-acting HIV prevention drug lenacapavir in Zimbabwe, aiming to support thousands of people.

Rachel Hagan speaks to some of researchers behind the push for a full HIV vaccine – whose trial had to be saved after the US ...

The U.S. will wind down health assistance to Zimbabwe after the African country withdrew from talks on a proposed $367 ...

The U.S. is winding down its health assistance to Zimbabwe after negotiations over a $367 million funding agreement broke ...

HARARE: Young women, mothers holding babies and some men lined up in a dusty field on the outskirts of Zimbabwe's capital, Harare. They came for injections of a ...

Zimbabwe has launched lenacapavir, an HIV prevention drug administered biannually, aiming to curb infections. While offering hope for at-risk groups, obstacles include funding and infrastructure. The ...

SADC region continues to lead globally in HIV response The United Nations Population Fund (UNFPA) Regional Director for East and Southern Africa, Lydia Zigomo, says the SADC region continues to lead ...